Angelica Afshari-Mehr

All papers authored by Angelica Afshari-Mehr

This paper was not found in any repository; the policy of its publisher is unknown or unclear.

2023 Alistair Ring

, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Table S5 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Figure S3 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Figure 2 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Figure 1 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Table S1 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Figure 3 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Data from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Figure S2 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Figure S1 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Table S2 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Table 2 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring

, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Table S4 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring

, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Supplementary Table S3 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Figure 4 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Alistair Ring, Lucy S. Kilburn, Alex Pearson, Laura Moretti, Angelica Afshari-Mehr

, Andrew M. Wardley, Bora Gurel, Iain R. Macpherson, Ruth Riisnaes

, Richard D. Baird, Sue Martin, Rebecca Roylance, Hannah Johnson, Ana Ferreira, Matthew C. Winter and 9 other authors

Table 1 from Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

This paper was not found in any repository, but could be made available legally by the author.

Alistair Ring

, Lucy S. Kilburn

, Alex Pearson

, Laura Moretti

, Angelica Afshari-Mehr

, Andrew M. Wardley

, Bora Gurel

, Iain R. Macpherson

, Ruth Riisnaes

, Richard D. Baird

, Sue Martin

, Rebecca Roylance

, Hannah Johnson

, Ana Ferreira

, Matthew C. Winter

and 9 other authors

Olaparib and Ceralasertib (AZD6738) in Patients with Triple-Negative Advanced Breast Cancer: Results from Cohort E of the plasmaMATCH Trial (CRUK/15/010)

Upload

Missing publications? Search for publications with a matching author name.

Researcher

Statistics

Refine

All papers authored by Angelica Afshari-Mehr